- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06743542
Assessment of Handwriting Skills in a Sample of Egyptian Children with Attention-Deficit Hyperactivity Disorder (ADHD)
December 16, 2024 updated by: Walid Saber Hussain, October 6 University
PURPOSE: To assess handwriting difficulties in ADHD children.
BACKGROUND: Attention deficit hyperactivity disorder (ADHD) is one of the most common neurodevelopmental disorders that affects 7.6% of children worldwide.
In addition to the core symptoms defining Attention-Deficit/Hyperactivity Disorder (ADHD), ADHD children often experience motor problems, including graphomotor movements, leading to handwriting difficulties.
Studies have confirmed that handwriting skills are adversely impacted by the presence of ADHD, and this is associated with lower academic achievement and self-esteem.
Children with ADHD have been found to display greater difficulties in the development of motor coordination, especially in the planning and execution of complex, lengthy, and novel chains of goal-directed behavior.
Also, handwriting problems in ADHD may signal underlying executive function deficits such as inhibition, emotional dysregulation, working memory problems, and difficulty with self-monitoring, all of which are required for various daily functions beyond handwriting per se.
With a slower motor response and perceptual speed, these deficits may decrease the likelihood that a child with ADHD can work efficiently and stay on-task during school and home activities.
Study Overview
Status
Completed
Detailed Description
Written informed consents will be obtained from the parents of participants. All participants will undergo the following:
- Thorough history taking and medical examination.
- Anthropometric measurements: weight, height
- Diagnosis by DSM 5
- Conners' Parent Rating Scales-Revised (CPRS-R) to assess the severity of ADHD symptoms.
- Intelligence quotient (IQ) test: Stanford Binet intelligence scale, fifth edition to assess the mental ages of the children and measure their intelligence quotients.
- Assessment of handwriting using (Handwriting Legibility Scale (HLS) to evaluate the handwriting skills of the participants including ……
- Assessment of neuropsychological abilities related to executive functioning and learning Using the Learning, Executive, and Attention Functioning (Leaf) scale.
- Language assessment to identify any underlying language deficits that might contribute to handwriting difficulties.
- A Baseline mechanical gauge was used to measure palmer pinch strength in kilograms
- A Baseline mechanical gauge was used to measure hand grip strength in kilograms
- Statistical analysis using the SPSS version 22.
Study Type
Observational
Enrollment (Actual)
70
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Giza, Egypt, 123
- October 6 University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Probability Sample
Study Population
ADHD children can read and write both sexes.
Description
Inclusion Criteria:
- ADHD children can read and write
- both sexes.
Exclusion Criteria:
- low IQ children
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Handwriting Skills
Time Frame: 3 monthe
|
3 monthe
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 15, 2024
Primary Completion (Actual)
September 15, 2024
Study Completion (Actual)
November 15, 2024
Study Registration Dates
First Submitted
October 25, 2024
First Submitted That Met QC Criteria
December 16, 2024
First Posted (Actual)
March 25, 2025
Study Record Updates
Last Update Posted (Actual)
March 25, 2025
Last Update Submitted That Met QC Criteria
December 16, 2024
Last Verified
December 1, 2024
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- o6u
- Assessment of Handwriting Skil (Other Identifier: O6U)
Drug and device information, study documents
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.